Cargando…
Skin Directed Therapy in Cutaneous T-Cell Lymphoma
Skin directed therapies (SDTs) serve important roles in the treatment of early stage cutaneous T-cell lymphoma (CTCL)/mycosis fungoides (MF), as well as managing symptoms and improving quality of life of all stages. There are now numerous options for topical therapies that demonstrate high response...
Autores principales: | Tarabadkar, Erica S., Shinohara, Michi M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470180/ https://www.ncbi.nlm.nih.gov/pubmed/31032224 http://dx.doi.org/10.3389/fonc.2019.00260 |
Ejemplares similares
-
Mechlorethamine Hydrochloride Gel in the Treatment of Mycosis Fungoides–Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Focus on Patient Selection and Special Considerations
por: Crimp, Caitlin, et al.
Publicado: (2022) -
Gender disparities in health-related quality of life (HRQoL) in patients with cutaneous T-cell lymphoma
por: Chalaka, Christopher W., et al.
Publicado: (2023) -
Health‐related quality of life in cutaneous T‐cell lymphoma: A cross‐sectional survey study
por: Shinohara, M.M., et al.
Publicado: (2021) -
New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma
por: Fujii, Kazuyasu
Publicado: (2018) -
Editorial: Cutaneous T-Cell Lymphomas
por: Chung, Catherine G., et al.
Publicado: (2021)